लोड हो रहा है...
Progression after Immunotherapy for Fibrolamellar Carcinoma
BACKGROUND: Fibrolamellar carcinoma (FLC) is a rare malignancy of the liver that differs from typical hepatocellular carcinoma (HCC) in several aspects such as the absence of underlying liver disease and occurrence in younger patients. Even though the survival rates in FLC are slightly better than i...
में बचाया:
| में प्रकाशित: | Visc Med |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
S. Karger AG
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597907/ https://ncbi.nlm.nih.gov/pubmed/31312648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497464 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|